JP EN

TBAP

Triple Bridge Acceleration Program

LEARN MORE

TBAP

Triple Bridge Acceleration Program

LEARN MORE
Triple Bridge Acceleration Program “TBAP” aims to support the commercialization of academic research in the medical and life science fields.

Overview

A collaborative program where each participant is tasked with achieving commercialization

Support

The Acceleration Program aims to support the commercialization of academic research in the medical and life science fields.

Awareness Building and Education

Preparing for Commercialization

Project Review

Funding and Resource Support

Academia

(Universities, research institutions, etc.)

  • Improve competitiveness as a research institution.
  • Enhance resources required for commercialization.

Businesses

(Pharmaceutical companies, medical device manufacturers, etc.)

  • Improve access to seed opportunities.
  • Mitigate early stage risk.

Investors

(VC, CVC, etc.)

  • Gain greater access to investment opportunities.
  • Enhance due diligence.

Collaboration

In TBAP, research institutions, strategic companies, and financial investors collaborate to commercialize academic research.

Team

Comprehensive coverage of the life science sector.

Membership

Corporate

The Acceleration Program outsourced to TBAP

Support / Affiliates

Management Company

TBAP is managed by AIFAM Asset Management in Japan, a wholly owned by AIFAM Group LLC (NY) .

Learn more about AIFAM